| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |